🇺🇸 US Stock Screener ← Switch market ⚡ HerAI

XAIR XAIR

Company Profile ↓
$3.13
-93.84% 1Y
Mkt Cap$1.85M
P/E-0.04
P/B0.52
52W High$54.00
52W Low$3.07
Book Value$10.39
EPS (TTM)$-80.20

Company Overview

XAIR (XAIR) is a publicly traded company listed on with a market capitalization of $1.85M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.

Recent Developments

  • Mar 2026 Revenue of $7.68M (+107.3% YoY); net profit $-33.25M.
  • Trailing 12 Months Year-on-year growth — revenue +107.3%.
  • 5-Year Trend Long-term compounding — revenue CAGR -0.1%.

Growth & Price Performance

Compounded Sales Growth

5 Years:-0.10%
1 Year:107.26%

Stock Price Performance

1 Year:-93.84%
6 Months:-81.14%
3 Months:-57.82%
1 Month:-50.44%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bearish
52-Week Range 0% of range
$3.07 $54.00
Trend Signals
  • Price vs 50-DMABelow
  • Price vs 200-DMABelow
  • RSI (14)29.70 · Oversold
Price Performance
1M-50.44%
3M-57.82%
6M-81.14%
1Y-93.84%

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

No notable strengths flagged.

CONS

  • Revenue declined at -0.1% CAGR over 5 years.
  • Trading 94.2% below its 52-week high.
  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
-0.04
Industry PE
-
Forward P/E
-
PEG Ratio
-
Book Value
$10.39
Price to Book
0.52
P/S
0.41
EV/EBITDA
-
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
-0.10%
Profit 5Y
-
Revenue (YoY)
107.26%
Earnings (YoY)
-

Profitability & Returns

ROCE
-100.59%
ROE
-
ROA
-93.96%
Profit Margin
-
Op Margin
-
Gross Margin
3.28%
EPS (Latest Qtr)
$-15.40
EPS (TTM)
$-80.20

Balance Sheet & Liquidity

Debt/Equity
3.82
Quick Ratio
3.59
Current Ratio
3.80
Debt
$23.38M
Total Assets
$35.38M
Current Assets
$24.77M
Working Capital
$18.26M

Ownership

Promoter Holding
11.22%
Chg in Prom Hold
-0.31%
FII / Inst Holding
7.00%
Chg in FII Hold
-0.20%

Financial Snapshot

Enterprise Value
$1.85M
Total Revenue (TTM)
$7.68M
EBITDA
$-27.17M
Free Cash Flow
$-19.17M
Operating Cash Flow
$-18.14M
Shares Outstanding
589.63K
Gross Margin
3.28%
Payout Ratio
-
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Mar 2016Jun 2016Sep 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Jun 2019Sep 2019Dec 2019Jun 2020Sep 2020Dec 2020Jun 2021Sep 2021Dec 2021Jun 2022Sep 2022Dec 2022Jun 2023Sep 2023Dec 2023Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue -----------627.47K645.60K314.38K229.16K350.00K149.00K------59.00K239.00K391.00K683.00K798.00K-1.15M1.76M1.82M2.19M1.91M
Cost of Revenue -----------------------------1.18M1.60M2.12M1.89M1.81M
Gross Profit ----------------------179.00K-68.00K-244.00K-193.00K-356.00K-332.00K-1.08M--32.00K156.00K-298.00K300.00K94.00K
Operating Expenses -----------------------------7.14M7.77M7.36M6.90M7.26M
Operating Income -923.00K-626.00K-167.00K3.57M-3.07M-2.06M2.38M-2.44M-1.76M-2.41M-2.40M-3.88M-4.27M-4.74M-6.60M-4.97M-5.62M-6.59M-6.20M-7.49M-11.44M-12.62M-14.01M-15.88M-17.54M-16.96M-13.58M-12.83M--7.17M-7.62M-7.66M-6.60M-7.17M
EBITDA ------------------------------6.54M-6.60M-6.70M-5.65M-8.21M
Interest Expense -----------------------------580.00K548.00K639.00K1.09M1.24M
Pretax Income ------------------------------8.06M-8.08M-8.26M-7.63M-10.37M
Tax Provision -----------------------------00000
Net Income -1.27M-970.00K-503.00K-6.28M-2.88M-7.15M-1.73M1.05M-1.72M-2.39M-2.37M-6.18M-4.10M-4.40M-6.74M-5.13M-5.77M-6.74M-8.69M-7.74M-10.93M-11.97M-12.75M-14.10M-16.22M-16.22M-12.20M-13.36M--8.03M-7.69M-7.94M-7.34M-10.28M
Diluted EPS -------0.280.14--0.11----------0.37-0.40-0.43-0.45-0.51-0.50-5.32-5.67--36.00-30.60-25.00-17.00-15.40
R&D Expense 224.00K271.00K78.00K1.44M591.00K1.19M1.21M1.64M1.06M647.87K588.26K2.32M2.85M2.58M4.33M3.15M3.29M2.74M2.81M2.54M3.23M4.45M5.00M4.70M7.13M6.84M6.01M4.58M3.00M-3.09M2.45M2.43M-

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2016Dec 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue ---7.72M1.39M873.00K-01.16M3.71M7.68M
Cost of Revenue -------555.00K2.47M5.37M7.43M
Gross Profit --------555.00K-1.31M-1.66M252.00K
Operating Expenses -------51.50M61.70M42.87M29.30M
Operating Income -2.33M-11.07M9.94M-3.06M-18.14M-22.21M-40.71M-52.06M-63.01M-44.54M-29.04M
EBITDA --------58.20M-59.03M-41.89M-27.17M
Interest Expense -------30.00K2.91M3.02M3.52M
Pretax Income --------59.40M-64.30M-48.48M-34.33M
Tax Provision -------0000
Net Income -3.72M-18.04M-10.72M-6.56M-19.94M-22.88M-43.18M-55.82M-60.24M-46.62M-33.25M
Diluted EPS --3.01--0.77----744.00-728.00-276.00-80.20
R&D Expense 673.00K4.44M4.64M3.93M10.65M12.62M11.80M16.81M24.36M16.86M10.24M

Balance Sheet (Annual)

Figures in USD.

Metric Apr 2015May 2015Dec 2015Dec 2016Dec 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets --5.56K236.00K2.19M9.36M9.43M27.43M40.52M-68.75M56.96M30.06M35.38M
Current Assets ----------59.41M43.94M16.02M24.77M
Cash & Equivalents 9001.00K129.00K7.00K1.20M732.54K1.34M19.83M34.63M-29.16M11.38M4.67M6.74M
Inventory ----------1.13M2.13M2.42M1.41M
Receivables ----------0319.00K710.00K1.09M
Total Liabilities --10.86K4.93M10.57M5.68M5.40M9.34M10.06M-26.72M29.77M15.72M29.18M
Current Liabilities --7502.04M1.40M2.13M5.40M4.87M3.80M-19.78M11.57M5.00M6.51M
Long Term Debt --------5.00M-120.00K14.72M9.20M21.64M
Total Debt ----------3.59M17.84M11.69M23.38M
Total Equity ---1.82M-4.70M-8.38M1.54M4.02M18.09M30.46M-37.91M25.05M13.58M6.13M
Shares Outstanding ----------76.85K114.75K206.43K589.63K

Cash Flows (Annual)

Figures in USD.

Metric Dec 2016Dec 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow -692.00K-7.12M-8.69M1.34M-15.25M-19.64M--33.01M-56.01M-38.22M-18.14M
Investing Cash Flow 14.00K-1.14M-8.52M-1.79M4.42M-890.00K--20.59M-12.23M14.90M-3.67M
Financing Cash Flow 556.00K9.46M10.81M1.07M34.93M30.33M-2.70M43.17M16.65M29.09M
Capital Expenditure --244.46K-219.59K-56.48K-43.63K-890.00K--3.88M-5.75M-5.88M-1.02M
Free Cash Flow --7.36M-8.91M1.28M-15.29M-20.53M--36.89M-61.76M-44.10M-19.17M
Net Change in Cash --------50.90M-25.08M-6.67M7.27M
Share Buybacks -25.00K---------

Ratios (Annual)

Figures in %.

Metric Dec 2016Dec 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Margin % ---------112.8%-44.9%3.3%
Operating Margin % ----39.6%-1,305.1%-2,544.6%---5,436.3%-1,202.1%-378.2%
Net Margin % ----84.9%-1,434.6%-2,620.3%---5,197.8%-1,258.4%-433.0%
ROE % 79.2%215.3%-693.9%-162.9%-110.2%-75.1%--147.2%-240.5%-343.3%-542.8%
ROCE % 129.4%-1,395.7%137.7%-76.0%-80.4%-60.5%--106.3%-138.8%-177.7%-100.6%

Shareholding Pattern

Insiders
11.22%
Institutions
7.00%
Public Float
7.88%

Top Institutional Holders

#Holder% HeldSharesValue
1 Balyasny Asset Management LP 2.42% 23.21K $103.97K
2 Murchinson Ltd. 1.43% 13.71K $61.42K
3 Daytona Street Capital LLC 0.79% 7.58K $33.95K
4 Geode Capital Management, LLC 0.59% 5.61K $25.14K
5 Bleichroeder LP 0.45% 4.32K $19.37K
6 Vanguard Capital Management LLC 0.33% 3.14K $14.05K
7 Commonwealth Equity Services, LLC 0.25% 2.37K $10.61K
8 Vanguard Fiduciary Trust Co 0.15% 1.47K $6.58K
9 Blackrock Inc. 0.12% 1.10K $4.94K
10 Stonex Group Inc. 0.11% 1.08K $4.83K

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for XAIR

Google News hu, 30 Jul 2026

FDA Approval Would Start a 45-Day Clock on Beyond Air Warrants - Stock Titan

<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxNeFBBUDBGYXZqd1Z2WHJBNDZCNUd0TWl5UnVhamhJMTVzeE9OelFUaWQ4NGNzSUl3SWxjZDlQN2EwMDJWTXdzSzZpa2V3RGNXMy1XMm0wNFZ4UjluX1JsWFpPUzdXZFMzZUJBVldYcHRhWjJvb0MwTVZZd3BhT0hPRnUwM2tSSFNReWdsS2…

Google News Fri, 28 Aug 2026

$XAIR stock is down 24% today. Here's what we see in our data. - Quiver Quantitative

<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxPOGFqM2F2YXpwdENpMUI2eVF2Z1JMU1cwaEVPRFVwNjFldXVDTURLalliRTZQSmEyaVphUWg0SXJaQU1ra2NXRld0YmV3a2ROZmRRMXc2cnNfRGt1d3M4UWtFLXhHRnl1Y3NZTjF3Smg1TlM5Zjc0T1BBVVdIczJxTEVSZW9HY2Y5SkIxY0…

Google News ue, 13 Jan 2026

XAIR Stock More Than Doubled Today — What’s Driving The Rally? - Stocktwits

<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxQb3pWanFhdDhkUG1TTFFrSTNSTVYzMTlGVzlkU2ZBcFhLZjk2UXF4WjFMazNsS1pTR005UnM5OFBpUE51RWZZSXluQUdNZGQ0QTRoblVsaVh5OUJEck9jSE9qUnNxVnBUMnFZQXpGbkowZEJSdUdDNUp4NXctUE52NXdBdHRGVzFnSGw2Mz…

Google News hu, 13 Aug 2026

BEYOND AIR ($XAIR) Releases Q1 2027 Earnings | XAIR Stock News - Quiver Quantitative

<a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxOSUQyR3MyMjV6Z0puVGdsc01NZ051TGtaeEhUZ2N0MlplVHRFZFA0NXg5azdlLUZVcGQ5Z3FTaEk2VkVyNWRKcUpldDUzVlZOSzVCNzNEZjhPU0RCSFJrQkZrNnN2TERWXzVUUFdLcnRQOWtFcTdFRk43bXlGWEptRzNRTzVxZlY4a0Q0?o…

Google News Wed, 02 Sep 2026

At the Waldorf Astoria, Beyond Air joins a healthcare conference Sept. 10 - Stock Titan

<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxPU1JnZVFuckFEZmNpWmJyb1YyZGZRbHRJYmx1UnZTdkM2bG45ZnlNemJ3alJGRUhuMWppcDR5MlhxcUdjWXI0am9KU0J6RHNFRXo0Q25qMldBWl9zS2M5dTQ3OVJ6Y200YzkzVFBrMHZoTmNEemYteGd3YUI4WF9kOEdKc0FBRFByN0c2bm…

Google News Mon, 22 Dec 2025

With Beyond Air Stock Sliding, Have You Assessed The Risk? - Trefis

<a href="https://news.google.com/rss/articles/CBMixgFBVV95cUxPTUFaVUhLQXREemJhMm9wOHQzbUx5bHVSaDZyMzRiQ1ZVek54cDJLQ2piNG1TcHA0WHJzakdacGVhQ2dVNnp3YXdZV041bENLTWZGTzYtWmJUNk5wcGdKUTJhZzEwUlVsMzk1azZlc1d3WXBpM09SeWdtRnU1cWtxMzI4T3VZQmc4My1QUn…

XAIR — Frequently Asked Questions

What is the current share price of XAIR?

As of 2026-09-16 18:39 PDT, XAIR trades at $3.13 on NASDAQ/NYSE. Its 52-week range is $3.07 to $54.00.

What is the market capitalisation of XAIR?

XAIR has a market capitalisation of $1.85M on NASDAQ/NYSE.

What is the P/E ratio of XAIR?

XAIR trades at a trailing price-to-earnings (P/E) ratio of -0.04. Its price-to-book (P/B) ratio is 0.52.

Is XAIR a good stock to buy?

This page provides a data-driven analysis of XAIR, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space